• Peptidisc-Assisted Nanobody Polybody Engineering

  2026-09-17

  Chen and Duong van Hoa describe a peptidisc-assisted strategy in which hydrophobic clustering drives nanobody multimerization without relying on tandem genetic linking or conventional oligomerization scaffolds. The resulting polybodies showed avidity-enhanced binding and could be configured as bispecific or autofluorescent assemblies, suggesting a flexible platform for nanobody engineering while leaving important questions about stoichiometry, stability, and broader applicability for future studies.

• RNA Tailoring for Translational Metabolism Research

  2026-09-17

  A mechanistic and strategic guide to using enzymatic polyadenylation to improve RNA performance while designing better experiments around the TCAIM–OGDH mitochondrial metabolism axis.

• Mifepristone (RU486): A Receptor-Aware Research Guide

  2026-09-16

  Mifepristone (RU486) is a progesterone receptor antagonist with applications spanning oncology and reproductive biology. This guide adds a phenotype-aware framework for interpreting its effects, using androgen receptor heterogeneity to improve assay design without conflating AR and PR biology.

• EMC Control of GABAA Receptor Proteostasis

  2026-09-16

  The reference study shows that the endoplasmic reticulum membrane complex, particularly EMC3 and EMC6, supports endogenous GABAA receptor surface trafficking and function. Its combination of subunit-specific depletion, interaction analysis, and rescue of disease-associated receptor variants connects ER membrane insertion machinery with neuronal receptor proteostasis.

• SERF and the Molecular Control of Amyloid Formation

  2026-09-15

  The dissertation “SERF is a modifier of amyloid formation” examines how SERF/MOAG-4 changes amyloid assembly through complementary biochemical, genetic, and cell-based approaches. Its main contribution is to position SERF as an active regulator of aggregation pathways rather than a passive marker of protein misfolding, while also showing why assay context matters when connecting molecular assembly to cellular phenotypes.

• Sorafenib Workflows for Tumor and Angiogenesis Models

  2026-09-14

  Use Sorafenib (BAY-43-9006) to connect RAF/MEK/ERK signaling, VEGFR biology, tumor proliferation inhibition, and angiogenesis in one experimentally controlled workflow. This guide emphasizes assay selection, practical dosing, reference comparators, and troubleshooting for hepatocellular carcinoma models and endothelial tube-formation studies.

• (+)-Bicuculline: Protocol and QC

  2026-09-14

  (+)-Bicuculline is a practical GABAA receptor antagonist for dissecting inhibitory neurotransmission, synaptic NMDA receptor signaling modulation, and related neuronal responses. This guidance addresses preparation, storage, controls, and interpretation; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical purposes.

• Reversible Labels for the Hidden Cell Surface

  2026-09-13

  A translational strategy for using Sulfo-NHS-SS-Biotin to interrogate cell-surface protein organization, glycoRNA-associated domains, and reversible affinity workflows without confusing protein labeling with direct RNA detection.

• AIBP-LRP2 Axis Restricts Collateral Circulation

  2026-09-12

  This Science Advances study identifies an AIBP–LRP2–HDL–miR-223 pathway that suppresses CXCR4+ stemlike capillary endothelial cells and limits collateral vessel formation after ischemia. Its two-phase model links lipid-associated RNA transport to endothelial state transitions, suggesting a mechanistic framework for improving revascularization strategies in peripheral artery disease.

• Oxaliplatin Workflows for DNA Damage Research

  2026-09-12

  Build reproducible Oxaliplatin experiments around fresh aqueous preparation, orthogonal cell-death readouts, and response modeling. The workflow also translates SMC2 and SMC4 findings in breast cancer into practical chemotherapy-sensitization assays without overstating cross-tumor evidence.

• Mechanical Stress and Cytoskeleton-Dependent Autophagy

  2026-09-11

  The reference study shows that compressive force-induced autophagy depends primarily on cytoskeletal microfilaments, while microtubules make a supporting contribution. By combining mechanical stimulation with chemical cytoskeletal perturbation, the work provides a direct framework for dissecting how cells convert physical stress into autophagic responses.

• Sorafenib in ATRX-Aware Cancer Research

  2026-09-11

  Sorafenib, also known as BAY-43-9006, is a multikinase probe for connecting RAF/MEK/ERK signaling, angiogenesis, and genotype-dependent drug sensitivity. This article translates ATRX-deficient glioma findings into practical assay design for cancer biology research.

• Sulfo-NHS-SS-Biotin: Cleavable Protein Labeling Guide

  2026-09-10

  Sulfo-NHS-SS-Biotin is a water-compatible, amine-reactive reagent for protein labeling, cell-surface studies, and affinity purification. Its disulfide spacer enables reversible biotin capture, while its hydrolysis-sensitive NHS ester requires fresh preparation and immediate use.

• De Novo Purine Biosynthesis Drives Rice Blast Virulence

  2026-09-10

  Liu and colleagues show that the de novo purine biosynthesis pathway is required for growth, stress tolerance, conidiation, and pathogenicity in Magnaporthe oryzae. Their MoAde8-centered genetic analysis also connects purine availability with MoTor activity and autophagy, providing a framework for studying metabolic control of fungal virulence.

• Protease Inhibitor Cocktail EDTA-Free: K1010

  2026-09-09

  Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during protein extraction and sample preparation for assays such as Western blotting, co-immunoprecipitation, and kinase analysis. It is appropriate when EDTA could interfere with divalent-cation-sensitive workflows, but it should not be treated as a phosphatase inhibitor or as a universal solution for every protease or enzyme assay.

8528 records 1/569 page Next 12345 下5页 Last page